Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 15, Issue 4, 2009, Pages 589-593

  Hommel, Kevin A ^a,b   Davis, Christine M ^c   Baldassano, Robert N ^c,d  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adherence; Compliance; Inflammatory bowel disease; Medication

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; 6 METHYLTHIOINOSINE; AZATHIOPRINE; THIOGUANOSINE; GASTROINTESTINAL AGENT;

ADOLESCENT; ARTICLE; BIOASSAY; CHILD; CHRONIC PATIENT; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CROHN DISEASE; DISEASE SEVERITY; ENTERITIS; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OBJECTIVE ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; SUBJECTIVE ASSESSMENT; BLOOD; CHILD PSYCHOLOGY; HOSPITALIZATION; ORAL DRUG ADMINISTRATION; PREVALENCE; PSYCHOLOGICAL ASPECT; STATISTICS;

ADMINISTRATION, ORAL; ADOLESCENT; ADOLESCENT PSYCHOLOGY; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MEDICATION ADHERENCE; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 67650107558     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20798     Document Type: Article

References (22)

1. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424-1429.
2. WHO. Adherence to Long-term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
3. Berg JS, Dischler J, WbLgner DJ, et al. Medication compliance: a healthcare problem. Ann Pharmacother. 1993;27(9 suppl):S1-24.
4. Lemanek K. Adherence issues in the medical management of asthma. J Pediatr Psychol. Aug 1990;15:437-458.
5. Rapoff MA. Adherence to Pediatric Medical Regimens. New York: Kluwer Academic; 1999.
6. Sly RM. Mortality from asthma in children 1979-1984. Ann Allergy. 1988;60:433-443.
7. Bernal I, Domenech E, Garcia-Planella E, et al. Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci. 2006;51:2165-2169.
8. Ediger JP, Walkker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel diease. Am J Gastroenterol. 2007;102:1-10.
9. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003; 98:1535-1544.
10. Hommel KA, Mackner LM, Denson LA, et al. Treatment regimen adherence in pediatric gastroenterology. J Pediatr Gastroeneterol Nutr. (in press).
11. Logan D, Zelikovsky N, Labay L, et al. The Illness Management Survey: identifying adolescents' perceptions of barriers to adherence. J Pediatr Psychol. 2003;28:383-392.
12. Mackner LM, Crandall WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:1006-1012.
13. Oliva-Hemker MM, Abadom V, Cuffari C, et al. Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2007;44:180-184.
14. Riekert KA, Drotar D. The Beliefs About Medication Scale: development, reliability, and validity. J Clin Psychol Med Sett. 2002; 9:177-194.
15. Belaiche J, Desager JP, Horsmans Y, et al. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease. Scand J Gastroenterol. 2001;36:71-76.
16. Cuffari C, Seidman EG, Latour S, et al. Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy. Can J Physiol Pharmacol. 1996;74: 580-585.
17. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118:705-713.
18. Kane S, Huo D, Aikens J, et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 2003; 114:39-43.
19. Zelikovsky NS, Schast AP. Eliciting accurate reports of adherence in a clinical interview: development of the medical adherence measure. Pediatr Nurs. 34:141-146.
20. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
21. Otley A, Loonen H, Parekh N, et al. Assessing activity of pediatric Crohn's disease: which index to use? Gastroenterology. 1999;116:527-531.
22. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330: 1841-1845.